Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.4M
-
Number of holders
-
289
-
Total 13F shares, excl. options
-
82.7M
-
Shares change
-
+2.73M
-
Total reported value, excl. options
-
$5.07B
-
Value change
-
+$182M
-
Put/Call ratio
-
0.26
-
Number of buys
-
152
-
Number of sells
-
-142
-
Price
-
$61.37
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2025
348 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2025.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 289 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.7M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (8.29M shares), RTW INVESTMENTS, LP (7.75M shares), BlackRock, Inc. (7.13M shares), WELLINGTON MANAGEMENT GROUP LLP (4.92M shares), JANUS HENDERSON GROUP PLC (3.77M shares), ARMISTICE CAPITAL, LLC (3.28M shares), TORONTO DOMINION BANK (3.25M shares), STATE STREET CORP (3.13M shares), D. E. Shaw & Co., Inc. (2.17M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.95M shares).
This table shows the top 289 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.